Loading...

Denosumab for the treatment of bone metastases in breast cancer: evidence and opinion

Introduction: Denosumab, a fully human monoclonal antibody, targets the receptor activator of nuclear factor-kappaB (RANK) ligand, a protein essential for osteoclast differentiation, activity and survival. Loss of osteoclasts from the bone surface reduces bone turnover and bone loss in malignant and...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Steger, Guenther G., Bartsch, Rupert
Format: Artigo
Sprog:Inglês
Udgivet: SAGE Publications 2011
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3169928/
https://ncbi.nlm.nih.gov/pubmed/21957430
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834011412656
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!